These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7033405)

  • 21. The adjuvant effect of microbial products on the immune response.
    White RG
    Annu Rev Microbiol; 1976; 30():579-600. PubMed ID: 185941
    [No Abstract]   [Full Text] [Related]  

  • 22. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

  • 24. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action mechanism of cell wall skeleton of BCG and Nocardia rubra as immunomodulator].
    Ogura T; Yoshimoto T; Sakatani M; Nishikawa H; Masuno T; Kawase I; Namba M; Hirao F; Yamamura Y; Itoh M
    Nihon Rinsho; 1981 Apr; 39(4):1852-60. PubMed ID: 7031297
    [No Abstract]   [Full Text] [Related]  

  • 26. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].
    Schwartz E
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):497-509. PubMed ID: 4152732
    [No Abstract]   [Full Text] [Related]  

  • 28. The cellular and molecular basis of immunity against mycobacterial diseases.
    Colston MJ
    Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enhanced immunogenicity of murine liver cells infected by MHV-3 (author's transl)].
    Bandlow G; Koszinowski U; Thomssen R
    Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):254-63. PubMed ID: 4377490
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of biological response modifiers in parasitic infections.
    Ruitenberg EJ; Buys J; Blomjous FJ; de Jong H; Bernadina W
    Dev Biol Stand; 1985; 62():129-38. PubMed ID: 3938740
    [No Abstract]   [Full Text] [Related]  

  • 31. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation of immunological adjuvant component from B.C.G. cells.
    Hiu IJ; Amiel JL
    Rev Eur Etud Clin Biol; 1971; 16(1):55-8. PubMed ID: 4929110
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between macrophage activity and serum haptoglobin levels.
    Palmer WG; Schueler RL
    Biomedicine; 1976 May; 25(3):88-90. PubMed ID: 181097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cancer immunotherapy and its fundamental basis (author's transl)].
    Yamamura Y
    Nihon Hifuka Gakkai Zasshi; 1976 Sep; 86(10):584-91. PubMed ID: 796500
    [No Abstract]   [Full Text] [Related]  

  • 36. Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. I. Action of mycobacterial adjuvants.
    Stark JM
    Immunology; 1970 Sep; 19(3):449-56. PubMed ID: 4919426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytostatic effect on MH134 hepatome cells by culture supernatant of active macrophage (author's transl)].
    Mizoguchi Y; Shiwa T; Higashimori T; Onishi F; Monna T
    Nihon Shokakibyo Gakkai Zasshi; 1979 Jul; 76(7):1550. PubMed ID: 491282
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
    Barlan I; Bahceciler NN; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):365-77, ix. PubMed ID: 16701150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phagocytosis of BCG by peripheral blood leucocytes of tuberculous patients complicated with diabetes mellitus (author's transl)].
    Hara T; Iwasawa K; Shinkai A; Miura K
    Kekkaku; 1980 Feb; 55(2):31-41. PubMed ID: 6990076
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of immunocompetent cells in the murine pulmonary granulomatous response induced by BCG (author's transl)].
    Konishi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Aug; 16(8):566-73. PubMed ID: 364130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.